#drug-discovery
A programmable lipid-triggered allosteric site modulates LC3 LIR receptor binding activity
The allosteric mechanisms by which lipid binding controls protein activity remain poorly understood. Here, the authors identify a lipid-triggered allosteric site in LC3 that remodels its receptor-binding interface upon membrane interaction. This site can be e…
Mayo Clinic Used AI to Design a Molecule Against a Pancreatic Cancer Protein Long Considered Undruggable
Mayo Clinic researchers used AI to design a small molecule targeting the GIPC1 PDZ domain in pancreatic cancer. What undruggable means and how early this is.
Preclinical Imaging Market Size to Reach USD 7.24 Billion by 2035 as Pharmaceutical R&D and Drug Discovery Investments Accelerate – SNS Insider
The U.S. Preclinical Imaging Market was valued at USD 1.12 Billion in 2025 and is projected to reach USD 1.85 Billion by 2035, while Europe is expected to grow from USD 1.28 Billion to USD 1.95 Billion, driven by expanding pharmaceutical research, imaging bio…
Global Drug Discovery Market Projected to Surpass USD 174.92 Billion by 2035 – SNS Insider
U.S. Drug Discovery Market to Hit USD 62.14 Billion by 2035 While Europe Advances Through Precision Medicine and Biologics Innovation. U.S. Drug Discovery Market to Hit USD 62.14 Billion by 2035 While Europe Advances Through Precision Medicine and Biologics I…
Strand Life Sciences marks a research milestone that aids drug discovery
The capability enabled by the ‘OlinkTM Explore HT’ platform helps measure over 5,400 protein biomarkers from just 2 μL of sample — roughly one-twenty-fifth of a single drop of blood
AI Training Dataset Market Trends Analysis Report Report 2026-2033: Expansive Datasets are Driving Advanced Applications in Drug Discovery, Precision Medicine, Genomics Research, and Healthcare AI
Key market opportunities in AI training datasets include the rising use of synthetic data to address data scarcity and privacy, increased demand for domain-specific datasets to enhance model accuracy, and automation in data labeling. Key sectors are healthcar…
Life Science Instrumentation Market Forecast Report 2025-2031: Expanding Activities in Genomics, Proteomics, and Drug Discovery with Thermo Fisher Scientific, Danaher, Agilent, and Shimadzu Leading
The global life science instrumentation market is forecasted to grow from USD 63.4 billion in 2025 to USD 92.5 billion by 2031, at a CAGR of 6.5%. Key drivers include increased R&D funding, rising proteomics research, and growing disease prevalence. In 2025, …
Global AI in Life Sciences Market Gearing Up for Outstanding Expansion at a CAGR of ~20% by 2034 | DelveInsight
The AI in life sciences market is experiencing robust expansion due to several important factors. Rising demand for accelerated drug discovery and development is prompting pharmaceutical and biotechnology companies to implement AI technologies that can shorte…
India Cell Based Assay Market Forecasts 2026-2035: Strategic Government Initiatives Bolster India's Biopharma Innovation
The India cell-based assay market is poised for growth due to increased drug discovery activities, automation in high-throughput screening, and outsourcing to CROs. Opportunities exist in 3D cell culture models, AI integration, stem cell research, oncology, a…
ERS Genomics and Aurigene Sign CRISPR/Cas9 License Agreement to Advance Precision Genome Editing in Drug Discovery
Agreement strengthens Aurigene's discovery platforms with access to foundational CRISPR/Cas9 intellectual property, enabling responsible innovation and enhanced global partner support DUBLIN and BANGALORE, India, May 13, 2026 /PRNewswire/ -- ERS Genomics Limi…